Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
Open Access
- 1 March 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Internal and Emergency Medicine
- Vol. 16 (2), 519-520
- https://doi.org/10.1007/s11739-020-02373-5
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patientsInternal and Emergency Medicine, 2020
- COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory FailureThrombosis and Haemostasis, 2020
- COVID-19 cytokine storm: the interplay between inflammation and coagulationThe Lancet Respiratory Medicine, 2020
- The role of heparin in sepsis: much more than just an anticoagulantBritish Journal of Haematology, 2017
- IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPδAmerican Journal of Physiology-Cell Physiology, 2007